Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027960 (mole)
 21,279 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

1. The lipids of Bacillus megaterium were extracted and three lipids containing glucosamine were identified. One of these is not a phospholipid, but the other two, which differ in their chromatographic behaviour, contain phosphorus, glycerol, fatty acid and d-glucosamine in the molar proportions 1:2:2:1. 2. In both phosphoglycolipids, the fatty acids are bound in ester linkage, and both yield 2,5-anhydromannose and 3-sn-phosphatidyl-1'-sn-glycerol on treatment with sodium nitrite. 3. Both phosphoglycolipids were N-acetylated and, after removal of fatty acids by mild alkaline hydrolysis, in both cases N-acetylglucosamine was quantitatively released by beta-N-acetylhexosaminidase. 4. The glucosaminylglycerols derived from the two phosphoglycolipids by partial acid hydrolysis differ in their behaviour towards periodate. In one case 1 mole of periodate is rapidly consumed/mole of glucosaminylglycerol, but in the other case under identical conditions the consumption of periodate is negligible. 5. The phosphoglycolipids were identified as 1'-(1,2-diacyl-sn-glycero-3-phosphoryl)-3'-O-beta-(2-amino-2-deoxy-d-glucopyranosyl)-sn-glycerol and as 1'-(1,2-diacyl-sn-glycero-3-phosphoryl)-2'-O-beta-(2-amino-2-deoxy-d-glucopyranosyl)-sn-glycerol. 6. Both phosphoglycolipids are good substrates for phospholipase A: neither is a substrate for phospholipase C from Clostridium perfringens, and only the 3'-glucosaminide is a substrate for phospholipase D.
 ...
PMID:Isomers of glucosaminylphospatiylglycerol in Bacillus megaterium. 430 9

1. A method was developed whereby [1-14C]glucosamine was used in a perfused rat liver system to prepare over 2 mg of alpha 1-acid glycoprotein with highly radioactive sialic acid and glucosamine residues. 2. The liver secreted radioactive alpha 1-acid glycoprotein over a 4-6 h period, and this glycoprotein was purified from the perfusate by chromatography on DEAE-cellulose at pH 3.6. 3. The sialic acid on the isolated glycoprotein had a specific radioactivity of 3.1 Ci/mol, whereas the glucosamine-specific radioactivity was 4.3 Ci/mole. The latter amino-sugar residues on the isolated protein were only 13-fold less radioactive than the initially added [1-14C]glucosamine. Orosomucoid with a specific radioactivity of 31.3 microCi/mg of protein was obtainable by using [6-3H]glucosamine. 4. The amino acid composition of the purified orosomucoid was comparable with that found by others for the same glycoprotein isolated from rat serum. A partial characterization of the carbohydrate structure was done by sequential digestion with neuraminidase, beta-D-galactosidase and beta-D-hexosaminidase. 5. Many other radioactive glycoproteins were found to be secreted into the perfusate by the liver. Thus this experimental system should prove useful for obtaining other serum glycoprotein with highly radioactive sugar moieties.
 ...
PMID:Use of radioactive glucosamine in the perfused rat liver to prepare alpha 1-acid glycoprotein (orosomucoid) with 3H- or 14C-labelled sialic acid and N-acetylglucosamine residues. 710 33

The correlation of Plasma beta-N-acetylglucosaminidase (NAG) activity and the development of diabetic retinopathy was observed in 117 diabetic patients (male 52, female 65) who had been observed for 2 years. The plasma NAG activity was measured at least 3 times per year (6 approximately 9 times altogether). The eye-ground findings at the beginning of the study and 2 years later were studied according to Scott's classification. Forty-four percent (19 cases) of the 43 patients with higher NAG activity (greater than 525 nmole/h/ml) and 27% (20 cases) of the 74 patients with lower NAG activity (less than or equal to 525 mole/h/ml) showed a worsening of the eye findings (p greater than 0.05). The frequencies of patients showing a worsening of the eye findings in patients with higher fasting blood glucose (FBG) values (greater than or equal to 140 mg/dl) and in patients with lower FBG values (less than 140 mg/dl) were 45% (17 in 38 cases) and 28% (22 in 79 cases), respectively (p greater than 0.1). When the NAG activity and the FBG value were considered together, there were 16 patients with both higher FBG values or higher NAG activity, and 52 patients with both lower FBG values and lower NAG activity. The frequencies of the patients who had a worsening of the eye findings were 56% (9 cases), 37% (18 cases), and 23% (12 cases), respectively. The difference was significant (p less than 0.05). In the present study, the plasma NAG activity showed no relation to diabetic retinopathy, but the results suggest that the plasma enzyme estimation may add further information to the FBG value and so help in predicting the development of diabetic retinopathy.
 ...
PMID:A follow-up study of plasma beta-N-acetylglucosaminidase activity and diabetic retinopathy--observed for 2 years. 710 61